Literature DB >> 458827

Blood glucose lowering sulfonamides with asymmetric carbon atoms. 3. Related N-substituted carbamoylbenzoic acids.

C Rufer, W Losert.   

Abstract

Both enantiomers of 4-N-[1-(5-Fluoro-2-methoxyphenyl)ethyl]carbamoylmethylbenzoic acid display hypoglycemic activity. The more potent (S) enantiomer is approximately equipotent with the acylaminoethylbenzoic acids of the type HB 699 (Figure 1; Table I). Observations are given that suggest that these benzoic acids act at the same receptor as the hypoglycemic sulfonylureas and sulfonylaminopyrimidines and further that this receptor includes important binding sites.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 458827     DOI: 10.1021/jm00192a028

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide.

Authors:  M G Garrino; W Schmeer; M Nenquin; H P Meissner; J C Henquin
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

2.  Effect of the hypoglycaemic drug (-)-AZ-DF-265 on ATP-sensitive potassium channels in rat pancreatic beta-cells.

Authors:  P Ronner; T L Hang; M J Kraebber; T J Higgins
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

3.  Highly potent and stereoselective effects of the benzoic acid derivative AZ-DF 265 on pancreatic beta-cells.

Authors:  M G Garrino; J C Henquin
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

4.  Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line.

Authors:  N C Sturgess; R Z Kozlowski; C A Carrington; C N Hales; M L Ashford
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.